[
    [
        {
            "time": "2023-05-14",
            "original_text": "【天风医药】沃森生物：与苏州艾博合作研发mRNA疫苗，研发加速助力长期发展",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "研发加速"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【天风医药】沃森生物：与苏州艾博合作研发mRNA疫苗，研发加速助力长期发展",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-05-14",
            "original_text": "司太立与恒瑞医药签署合作协议 发力国内造影剂制剂市场",
            "features": {
                "keywords": [
                    "司太立",
                    "恒瑞医药",
                    "造影剂制剂",
                    "合作协议"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "司太立与恒瑞医药签署合作协议 发力国内造影剂制剂市场",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-14",
            "original_text": "恒瑞医药获得两项药品临床试验通知书",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "临床试验",
                    "药品"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药获得两项药品临床试验通知书",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-05-14",
            "original_text": "子公司向医生行贿，销售费用遭质疑，恒瑞医药回应了！ 其他违规处罚",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "子公司",
                    "行贿",
                    "销售费用"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "子公司向医生行贿，销售费用遭质疑，恒瑞医药回应了！ 其他违规处罚",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-14",
            "original_text": "高瓴出手，这两家公司市值一日暴涨46亿",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "市值暴涨"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴出手，这两家公司市值一日暴涨46亿",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-14",
            "original_text": "再融资新规后首个案例 高瓴资本与凯莱英达成战略合作",
            "features": {
                "keywords": [
                    "再融资新规",
                    "高瓴资本",
                    "凯莱英",
                    "战略合作"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "再融资新规后首个案例 高瓴资本与凯莱英达成战略合作",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-05-14",
            "original_text": "重磅文件流出，基药目录调整，促进上下衔接，千亿市场爆发",
            "features": {
                "keywords": [
                    "基药目录",
                    "政策调整",
                    "市场爆发"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "重磅文件流出，基药目录调整，促进上下衔接，千亿市场爆发",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]